VBS Fellows’ Foray – Video Challenge 2019

Name: VBS Fellows’ Foray – Video Challenge 2019
Uploaded: 2019-08-15T08:00:00+00:00
Description: Recording of the live VBS Fellows’ Foray – Video Challenge 2019! This continuing medical education activity is supported through educational grants from

Overview
Recording of the live VBS Fellows’ Foray – Video Challenge 2019! This continuing medical education activity is supported through educational grants from Regeneron Pharmaceuticals, Inc. and Carl Zeiss Meditec, Inc.
Learning Objectives
Learning ObjectivesUpon completion of this activity, the participant should be able to:
- Identify a wide variety of treatment approaches for numerous vitreoretinal disease states.
- Compare the most recent monotherapy and combination therapy clinical study evidence using available therapies for AMD, DME, and RVO.
- Evaluate which patients may benefit from a specific regiment of care (e.g. treat-and-extend regimen, prn, mandated treatment approach).
- Develop individualized treatment plans for patients with retina disorders that use a combination of imaging and clinical findings.
- Apply case study examples to real world clinical settings.
Accreditation
Accreditation Statement Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement Evolve Medical Education LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity. The following fellows/faculty members have the following financial relationships with commercial interests: Tara McCannel, MD, PhD; D. Wilkin Parke III, M.D.; Dimitra Skondra, MD, PhD; Camila Ventura, MD, PhD; Christopher Adam, MD; Nicolas Crim, MD; Avner Hostovsky, MD; Rehan Hussain, MD; Talia Kaden, MD; Steven Saraf, MD; Sidney Schechet, MD; Peter Tang, MD, PhD, have no financial relationships with commercial interests. Aleksandra V. Rachitskaya, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, & Carl Zeiss Meditec. Anton Orlin, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Carl Zeiss Meditec. Pravin U. Dugel, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/ Advisory Board Member: Abbott/AMO, Acucela, Aerie Pharmaceuticals, Aerpio, Alcon, Alimera Sciences, Allergan, Amgen, Annidis, ArticDX, Avalanche, Bausch & Lomb, Boehringer Ingelheim, ByeOnics, Carl Zeiss Meditec, Chengdu Kanghong Biotechnology, Clearside Biomedical, CDR-Life, Inc., Digisight, Dose Medical, Genentech, Graybug Vision, Irenix, Kodiak Sciences, Lutronic, Lux BioScience, Macusight, NeoVista, Neurotech, Novartis, Oculis, Ophthotech, Omeros, Opthea, Optovue, ORA, Orbis International, Panoptica, Pentavision, pSivida Corporation, QLT, Inc., Regeneron, Roche, Santen, SciFluor Life Sciences, Shire Human Genetics, Spark Therapeutics, Stealth Biotherapeutics, Thrombogenetics, Topcon, and TrueVision, Stock/Shareholder: Aerpio, Alimera, Annidis, ArctixDx, Clearside Biomedical, Digisight, Irenix, Ophthotech and PanOptica. Phillip Ferrone, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Genentech; Grant/Research Support: Genentech; Samsung; Stock/Shareholder: ArcticDx. Editorial Support Disclosures, Susan Gallagher-Pecha, Director of client services and project management, Evolve, has no financial relationships with commercial interests.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 08/15/2019
Expiration Date: 08/31/2020